Elevance Health, Inc. — Director's Dealing 2012

Dec 12, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WELLPOINT, INC (WLP)
CIK: 0001156039
Period of Report: 2012-12-10

Reporting Person: DeVeydt Wayne S (EVP & Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-10	Common Stock	F	12684	$58.21	Disposed	105138.08	Direct
2012-12-11	Common Stock	M	38453	$30.10	Acquired	143591.08	Direct
2012-12-11	Common Stock	S	36373	$58.05	Disposed	107218.08	Direct
2012-12-11	Common Stock	S	60419	$58.37	Disposed	46799.08	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-12-11	Employee Stock Option (Right to Buy)	$30.10	M	38453	Disposed	2016-03-02	Common Stock (38453)	Direct

Footnotes

F1: Payment of tax liability by withholding stock incident to the vesting of previously granted restricted stock.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2012.

F3: This transaction was executed in multiple trades at prices ranging from $57.28 to $58.27. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $58.28 to $58.49. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: Exercised options vested as follows: 19,226 on 9/2/2011 and 19,227 on 3/2/2012.